
Andreas Ullern
- PhD student; MD
- 91195324
Publications 2025
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937
Publications 2024
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer
Mol Oncol, 19 (4), 1229-1243
DOI 10.1002/1878-0261.13760, PubMed 39545921